CMRA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CMRA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Comera Life Sciences Holdings has the GF Value Rank of 0.
The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.
GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).
We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.
After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Thank you for viewing the detailed overview of Comera Life Sciences Holdings's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael Gerard Campbell | officer: Chief Financial Officer | C/O COMERA LIFE SCIENCES HOLDINGS, INC., 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Charles Cherington | 10 percent owner | ONE BOW STREET, CAMBRIDGE MA 02138 |
David Soane | 10 percent owner | C/O SOANE LABS, LLC, 380 NE 72ND TERRACE, MIAMI FL 33138 |
Robert Patrick Mahoney | officer: Chief Scientific Officer | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Barbara K Finck | director | C/O PROTINE DESIGN LAB, 3858 JACKSON ST, SAN FRANCISCO CA 94118 |
Kirsten Flowers | director | C/O KURA ONCOLOGY, INC., 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO CA 92130 |
James Sherblom | director | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Stuart A Randle | director | 585 WEST 500 SOUTH, BOUNTIFUL UT 84010 |
Sullivan Edward Aloysius Jr. | director | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Sirshendu Roopom Banerjee | director | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Janice Mccourt | officer: Chief Business Officer | C/O COMERA LIFE SCIENCES HOLDINGS, INC., 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Jeffrey S. Hackman | director, officer: See Remarks | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
John D. Yee | director | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Neal Muni | officer: See Remarks | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Phoenix Venture Partners Lp | 10 percent owner | 36 DOCKSIDE CIRCLE, REDWOOD SHORES CA 94065 |
From GuruFocus
By Stock market mentor Stock market mentor • 01-12-2023
By Marketwired • 07-20-2023
By sperokesalga sperokesalga • 04-27-2023
By Stock market mentor Stock market mentor • 01-04-2023
By Marketwired • 09-12-2023
By Value_Insider Value_Insider • 11-09-2022
By Marketwired • 08-16-2023
By Business Wire Business Wire • 06-22-2022
By Stock market mentor Stock market mentor • 01-05-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.